Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018

被引:2
作者
Pompeo, Carolina Mariano [1 ]
Ferreira Junior, Marcos Antonio [1 ]
de Queiroz Cardoso, Andreia Insabralde [1 ]
Souza, Mercy da Costa [2 ]
Frota, Oleci Pereira [1 ]
Mota, Felipe Machado [1 ]
Ivo, Maria Lucia [2 ]
机构
[1] Univ Fed Mato Grosso do Sul, Integrated Inst Hlth, Campo Grande, MS, Brazil
[2] Univ Fed Mato Grosso do Sul, Grad Program Hlth & Dev Midwest Reg, Campo Grande, MS, Brazil
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2022年 / 15卷
关键词
hematologic diseases; early diagnosis; neonatal screening; survival; epidemiology; DISEASE; HYDROXYUREA; CHILDREN; MORBIDITY; AMERICA; ADULTS; LIVER; RISK;
D O I
10.2147/IJGM.S342971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To analyze the clinical-epidemiological characteristics and mortality in patients with sickle-cell anemia (SCA). Patients and Methods: A cohort study with retrospective data, conducted in two reference hospitals for SCA treatment from January 1980 to December 2018, recorded in two reference services. With a 5% significance level, the Chi-Square and Student's t-tests were employed in the inferential statistical analysis. Results: A total of 128 patients with SCA were studied. Diagnosis up to the fifth day of life was made in 10 patients. There were 19 deaths, of which 12 (63.2%) were female, and the average age at death was 27.05 (+/- 14.78) years. The leading causes of death were septic shock and cardiogenic shock. The use of invasive medical devices was considered a risk factor for death (RR=2.63; 95% CI=1.16-5.96; p=0.018), and monitoring time up to 20 years presented a 31% reduction in the risk of dying (RR=0.31; 95% CI=0.12- 0.82; p=0.011) when compared to the monitoring of more than 20 years. Conclusion: These findings are to be considered in the treatment of patients with SCA, mainly regarding early diagnosis and access to the treatment immediately afterward, since they are fundamental in improving survival and reducing severe complications.
引用
收藏
页码:1057 / 1074
页数:18
相关论文
共 68 条
[1]  
Abboud Miguel R, 2020, Hematol Oncol Stem Cell Ther, V13, P85, DOI 10.1016/j.hemonc.2019.12.007
[2]   Correlation of Serum Ferritin Levels with Liver Iron Concentration By MRI Measurement in Sickle Cell Patients with Transfusional Iron Overload [J].
Ajebo, Germame ;
Mangaonkar, Abhishek A. ;
Ahmad, Imran ;
Barrett, Nadine ;
Wells, Leigh ;
Patel, Niren ;
Xu, Hongyan ;
Kutlar, Abdullah .
BLOOD, 2018, 132
[3]  
Aleluia Milena Magalhaes, 2017, BMC Hematol, V17, P15, DOI 10.1186/s12878-017-0087-7
[4]   Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality [J].
Allareddy, Veerajalandhar ;
Roy, Aparna ;
Lee, Min Kyeong ;
Nalliah, Romesh P. ;
Rampa, Sankeerth ;
Allareddy, Veerasathpurush ;
Rotta, Alexandre T. .
PLOS ONE, 2014, 9 (04)
[5]  
[Anonymous], 2010, International statistical classification of diseases and related health problems - 10th revision
[6]  
Arduini Giovanna Abadia Oliveira, 2017, Rev. Bras. Hematol. Hemoter., V39, P52
[7]  
Brazilian Institute of Geography and Statistics, 2019, COMPL MORT TABL BRAZ
[8]  
Brazilian Institute of Geography and Statistics, 2020, RES POP FED UN MAJ R
[9]  
Cesar Purim, 2019, Hematol Oncol Stem Cell Ther, V12, P204, DOI 10.1016/j.hemonc.2019.04.002
[10]   Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease [J].
Chaturvedi, Shruti ;
Ghafuri, Djamila Labib ;
Kassim, Adetola ;
Rodeghier, Mark ;
DeBaun, Michael R. .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (02) :125-130